QIAGEN N.V. QGEN has secured FDA clearance for its QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, bolstering its syndromic testing portfolio in the United States. This marks the ...
The latest authorised panel targets bacterial infections, including Campylobacter, Shigella, Yersinia enterocolitica, and ...
2007 Margaret Werminski. Detection of Shiga toxin-producing Escherichia coli (STEC) in Clinical Stool Specimens by the Polymerase Chain Reaction (PCR). 2003 Philip Barruel. Isolation and Detection of ...